Perspectives
Drug Pipeline Quarterly Update: September 2020
Drugs in review, drugs with expiring patents, generic availability and more.
September 30, 2020These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status from the FDA, potential blockbuster drugs and the dates of expected FDA approval, names of top selling brand-name drugs with generic availability in the past 12 months and names of top selling brand-name drugs that have patents expiring soon.
Related news
Perspectives
August 15, 2022
September 2022 decisions expected from the FDA
At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to…
Perspectives
August 4, 2022
Specialty Pipeline Update: July 2022
This monthly pipeline wrap-up provides a review of newly approved specialty drugs, recent…
Perspectives
August 4, 2022
Traditional Drug Pipeline Update: July 2022
This monthly pipeline wrap-up provides a review of newly approved traditional drugs, recent…